GlassScriptPhysician profile
Haris Zafarullah
NPI 1841370475
$4,654.18
in general payments reported to CMS, 2019-2025
22 companies · $501 in 2025
The $501 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,835 · 2020: $1,103 · 2021: $106 · 2022: $254 · 2023: $659 · 2024: $196 · 2025: $501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,355.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,374.46 | 2019 | |
| Boston Scientific Corporation | $1,364.87 | 2019-2025 | Avvigo Guidance System, Eluvia |
| Medtronic, INC. | $568.28 | 2022-2025 | Symplicity G3, Onyx Frontier, Resolute Onyx |
| Shockwave Medical, INC | $341.60 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $242.10 | 2021-2023 | |
| Livanova USA, INC. | $215.84 | 2019 | |
| Amgen INC. | $125.61 | 2019-2023 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $77.88 | 2019-2021 | |
| Abiomed | $63.78 | 2023-2025 | Impella |
| Bayer Healthcare Pharmaceuticals INC. | $40.27 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $40.06 | 2019-2024 | Lifevest |
| Cordis US Corp. | $24.36 | 2025 | Mynx Control |
| Regeneron Healthcare Solutions, INC. | $22.74 | 2019 | |
| Bard Peripheral Vascular, INC. | $19.79 | 2019 | |
| Abbott Laboratories | $19.21 | 2023 | Perclose Prostyle |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $18.69 | 2024 | Optowire |
| Pfizer INC. | $18.52 | 2025 | |
| Baxter Healthcare | $18.34 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Astrazeneca Pharmaceuticals LP | $16.59 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.92 | 2021 | |
| Amarin Pharma, INC. | $14.37 | 2019 | |
| Philips North America LLC | $11.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haris Zafarullah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.